Synovus Financial’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$486K Sell
13,500
-4,500
-25% -$162K 0.01% 670
2025
Q1
$710K Sell
18,000
-1,500
-8% -$59.1K 0.01% 566
2024
Q4
$587K Sell
19,500
-400
-2% -$12K 0.01% 601
2024
Q3
$465K Buy
+19,900
New +$465K 0.01% 698